News zum Sektor Gesundheit aus Indien

 

Wall Street has significantly invested in Indian hospitals, focusing on expanding hospital infrastructure and care capacity. This influx of foreign capital has helped private healthcare providers grow, yet costs are escalating for patients. Medical inflation is alarming, with treatment at private facilities vastly outpacing public healthcare costs. Insurers and hospitals are grappling over rising medical expenses and coverage limitations for patients....

Indians will get the country's first dengue vaccine Qdenga next year, a key milestone to control the infectious disease that is a major public health concern for the South Asian nation....

Großer Auftrag für Rüstungs- und Technologieunternehmen Hensoldt +++ Börsen fürchten steigende US-Zinsen +++ Biontech stoppt Darmkrebs-Studie +++ Was passiert mit den Filialen der insolventen Baumarktkette Hellweg? +++ Neuigkeiten im Unternehmen-Liveblog....

KKR & Co. agreed to acquire Medicover AB's Indian hospital operations as the US private equity firm seeks to expand its health-care investments in the world's most populous country....

WASHINGTON (dpa-AFX) - KKR & Co. Inc. (KKR) on Thursday agreed to acquire Medicover India, the Indian hospital operations of Medicover AB (MCOV B.ST, MCVEF), for an undisclosed amount.The acquisit......

Um den gesamten Artikel unter asia.nikkei.com zu lesen, klicken Sie bitte auf die Überschrift...

Um den gesamten Artikel unter asia.nikkei.com zu lesen, klicken Sie bitte auf die Überschrift...

CEO of Indian pharma company Dr Reddy's has warned that Trump's proposed tariffs on generic drugs will make them more expensive for patients....

UBS Warns Trump's 100% Generic Drug Tariff Puts Indian Pharma "On Notice"; Goldman Flags Reshoring Winners President Trump will impose a 100% tariff on imported generic drugs starting in August 2028, rising to 200% a year later, unless manufacturers shift production to the US. "This is done in order to RESHORE Generic Pharmaceutical Production into America, with a penalty to those Companies that decide not to build Plant and Equipment within the stated period of time given to them," Trump wrote on Truth Social late Tuesday. He continued, "The objective of this Policy is to protect the people of the United States. The Policy on Patented, Branded, or Innovative Drugs, which has been so successful, will remain as is," adding, "Pharmaceutical Facilities are being built, at a level never seen before, all over the United States of America." Trump's announcement is the latest effort to reshore critical supply chains, and in this case, boost domestic productio...

Um den gesamten Artikel unter asia.nikkei.com zu lesen, klicken Sie bitte auf die Überschrift...

US President Donald Trump on Tuesday announced the final stage of his pharmaceutical tariff plan, under which imported generic medicines will continue to enter the US without duties until August 1, 2028....

Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

Um den gesamten Artikel unter asia.nikkei.com zu lesen, klicken Sie bitte auf die Überschrift...

Um den gesamten Artikel unter timesofindia.indiatimes.com zu lesen, klicken Sie bitte auf die Überschrift...

Manipal Health Enterprises Pvt., which runs the Manipal Hospitals chain, is likely to launch its initial public offering as early as next month, according to people familiar with the matter....

Indian drugmaker Biocon Ltd. is aiming to become the world's top supplier of insulin in the coming years, its co-founder Kiran Mazumdar-Shaw said, by capturing growing demand for the critical drug while Big Pharma shifts its focus to other medicines....

Carlyle Group Inc. has invited pitches from investment banks to advise on a potential India initial public offering of its recently acquired healthcare billing service business, according to people familiar with the matter....

State Bank of India plans to join a group of global lenders in funding Sun Pharmaceutical Industries Ltd.'s $12 billion overseas acquisition, according to people familiar with the matter....

Customs records show millions of dollars' worth of the high-strength synthetic opioid being shipped from India every month to Nigeria, Sierra Leone and Ghana....

Biocon CEO, Shreehas Tambe, discusses their push into the generic GLP-1 market, after Novo Nordisk cut prices of its blockbuster weight-loss and diabetes medications in India. He also spoke about the company's latest set of earnings on Insight with Haslinda Amin. (Source: Bloomberg)...